Idanpramine
Chemical compound
- A03AX06 (WHO)
- 5,5-Bis(4-methoxyphenyl)-3-[2-(piperidin-1-yl)ethyl]imidazolidine-2,4-dione
- 25466-44-8
Y
- 58521
- 52728
N
- 8WIO2013UA
- DTXSID20180151
- Interactive image
- C1CCCCN1CCN2C(=O)NC(C2=O)(c3ccc(OC)cc3)c4ccc(OC)cc4
InChI
- InChI=1S/C24H29N3O4/c1-30-20-10-6-18(7-11-20)24(19-8-12-21(31-2)13-9-19)22(28)27(23(29)25-24)17-16-26-14-4-3-5-15-26/h6-13H,3-5,14-17H2,1-2H3,(H,25,29)N
- Key:HVYGXNYMNHSBGD-UHFFFAOYSA-NN
N
Y (what is this?) (verify)Idanpramine is a drug used for functional gastrointestinal disorders. It acts as an antimuscarinic agent.[1]
References
- ^ "Idanpramine". Inxight Drugs. National Center for Advancing Translational Sciences.
- v
- t
- e
Drugs for functional gastrointestinal disorders (A03)
functional
bowel
disorders
| Antimuscarinics |
| ||||
|---|---|---|---|---|---|
| Phosphodiesterase inhibitors | |||||
| Acting on serotonin receptors |
| ||||
| Other |
and derivatives
(antimuscarinics)
- Tertiary amines: Atropine
- Hyoscyamine
- Quaternary ammonium compounds:
- Methylatropine
- Fentonium bromide
- Cimetropium bromide
 | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
